FirsthandHealth
medRxiv PreprintsInternational10 November 2026

Peripheral Blood NADP(H) Redox Metabolism in Alzheimers Disease and Mild Cognitive Impairment: A Systematic Review and Meta-analysis Where Feasible

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Background: The reduced and oxidized forms of nicotinamide adenine dinucleotide phosphate (NADPH/NADP) connect cellular reducing power with the glutathione and thioredoxin systems. Peripheral alterations in this network may reflect systemic redox dysregulation in Alzheimer s disease (AD) and mild cognitive impairment (MCI), but the evidence has not been quantitatively synthesized. Objective: To systematically evaluate peripheral blood NADP(H) redox metabolism and related enzymes in AD and MCI and to perform meta analyses when the available data were sufficiently comparable.
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.